Trump orders new pharma tariff, reshapes metal duties

The latest pair of orders he signed pile pressure on pharmaceutical companies to manufacture more in the United States, while separately targeting firms that officials accuse of "artificially manipulating" metals prices. Finished products containing substantial amounts of steel, aluminum and copper will also face a lower 25-percent tariff on their full value instead of being targeted for the amount of metals they contain, a move to simplify an onerous system for firms. It is not immediately clear how these would affect consumer prices...